Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

Trastuzumab improves gastric cancer survival for patients with HER2-positive disease

Trastuzumab improves gastric cancer survival for patients with HER2-positive disease

Adding bevacizumab to adjuvant chemotherapy does not improve disease-free survival

Adding bevacizumab to adjuvant chemotherapy does not improve disease-free survival

Menopausal hormone therapy with estrogen and progestin linked to increased risk of death in women

Menopausal hormone therapy with estrogen and progestin linked to increased risk of death in women

Genetic testing for breast or ovarian cancer risk not incorporated into clinical practice

Genetic testing for breast or ovarian cancer risk not incorporated into clinical practice

Avastin (bevacizumab) increases risk of hole in stomach and bowels

Avastin (bevacizumab) increases risk of hole in stomach and bowels

African american women miss out on vital breast cancer treatment

African american women miss out on vital breast cancer treatment

Fanconi anaemia pathway gives greater targeting hope

Fanconi anaemia pathway gives greater targeting hope

Genetic test reduces need for second surgery

Genetic test reduces need for second surgery

Androgen-receptor: a new drug target in breast cancer

Androgen-receptor: a new drug target in breast cancer

Gene signature identifies patients who will respond to chemo

Gene signature identifies patients who will respond to chemo

More from ecancer